MoneyWorks4Me

Gland Pharma informs about analyst meet

08 Nov 2024 Evaluate
Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015; Gland Pharma has informed that it enclosed the schedule of the Analyst/ Institutional Investor Meetings with the Company to be held on 11th November, 2024.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1759.90
Dr. Reddys Labs. 1228.00
Cipla 1306.75
Lupin 1944.05
Zydus Lifesciences 1123.90
View more..